Enlivex Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72k | 69k | 1.04 |
| 2025-06-30 | $89k | 79k | 1.12 |
| 2025-03-31 | $118k | 122k | 0.97 |
| 2024-12-31 | $25k | 21k | 1.17 |
| 2024-09-30 | $40k | 24k | 1.68 |
| 2024-06-30 | $28k | 20k | 1.42 |
| 2024-03-31 | $276k | 73k | 3.79 |
| 2023-12-31 | $40k | 15k | 2.70 |
| 2023-09-30 | $70k | 44k | 1.58 |
| 2023-06-30 | $144k | 55k | 2.63 |
| 2023-03-31 | $246k | 68k | 3.64 |
| 2022-12-31 | $664k | 170k | 3.90 |
| 2022-06-30 | $80k | 18k | 4.52 |
| 2021-12-31 | $138k | 22k | 6.27 |
| 2021-09-30 | $299k | 30k | 9.87 |
| 2021-06-30 | $420k | 47k | 8.93 |
| 2021-03-31 | $567k | 51k | 11.11 |
| 2020-12-31 | $882k | 105k | 8.42 |